Introduction
Methods for genetic code expansion provide valuable strategies for introducing non-proteinogenic functionalities into recombinant proteins.
[1] Ap articularly versatile approach in this context is the amber stop codon suppression methodology, which relies upon the use of an engineered aminoacyl-tRNA synthetase (aaRS)/tRNA CUA pair for reassigning an amber stop codon (TAG) with ad esired noncanonical amino acid (ncAA). [1a] This methodology has enabled the site-selective incorporation of ncAAs for av arietyo fa pplications, including protein conjugation and imaging, [2] controlling and modulating protein/ enzyme function, [3] and generating post-translationally modified proteins, [4] amongo thers. [5] Pyrrolysyl-tRNA synthetases (PylRSs) from Methanosarcina species [6] represent ap articularly attractive choicef or genetic code expansion, in large part due to the orthogonal reactivity of PylRSs and cognate tRNA Pyl molecules in both bacterial (Escherichia coli)a nd eukaryotic cells. [7] Initially identified for their ability to incorporate pyrrolysine in response to in-frame UAG codons, [6] PylRSs were found to be able to recognize an umber of (pyrro)lysine derivatives. [4b, 8] Aw ell-known challenge associated with the use of amber stop codon suppression is the competition between the ribosomal incorporation of the targetn cAA with termination of translation in response to the stopc odon.A saresult, the ncAA incorporation efficiency of orthogonal aaRSs, in particular by those derived from PylRSs, is often reduced compared to sense codon translation,r esulting in moderate expression yields for the target ncAA-containing protein. Over the past years, several strategies have been investigated to address this limitation, which include optimization of the promoters and copy numberso fa aRS and/or tRNA genes, [9] engineering of the tRNA molecule, [10] removal/manipulation of components of the translational machinery (e.g.,E F-Tu, RF1), [11] optimization of sequence contexts, [12] and genome-wide engineering of the host cell. [13] These methods have provene ffective toward improvingt he yield of ncAA-containing proteins, but they are not specifically aimed at improving the properties of the aaRSs. In fact, whereas major efforts have focused on altering the substrate specificity of aaRSs-a goal typicallya chieved through powerful selection-based methods [1a] -far fewer studies have been directed at improvingt he intrinsic properties of these enzymes as part of as top codon suppressor system. Recently,M atsuura and co-workersr eported al iposome-based in vitro evolution method for this purpose. [14] In spite of the high-throughput capability of this system,t he Methanosarcina mazei PylRS variantsi solated according this method showed either parent-like or only slightly improved (+ +70 %) in vivo incorporation efficiency compared to the parente nzyme, which furtherh ighlighted the challenge of developing aaRSs with inherently improved in vivo activity for ncAA mutagenesis.
Genetic code expansion through amber stop codon suppression provides apowerful tool for introducing non-proteinogenic functionalities into proteins for ab road range of applications. However,r ibosomal incorporation of noncanonical amino acids (ncAAs) by meanso fe ngineered aminoacyl-tRNA synthetases (aaRSs) often proceeds with significantly reduced efficiency compared to sense codon translation. Here, we report the implementation of aversatile platform for the development of engineered aaRSs with enhanced efficiency in mediating ncAA incorporation by amber stop codon suppression. This system integrates aw hite/blue colonys creen with ap latebased colorimetric assay,t hereby combining high-throughput capabilities with reliable and quantitative measurement of aaRS-dependent ncAA incorporatione fficiency.T his two-tier functional screening system was successfully appliedt oo btain ap yrrolysyl-tRNA synthetase (PylRS) variant (CrtK-RS(4.1)) with significantly improved efficiency (+ +250-370%)f or mediating the incorporationo fN e -crotonyl-lysine and other lysinea nalogueso fr elevance for the study of protein post-translational modifications into at arget protein. Interestingly,t he beneficial mutationsa ccumulated by CrtK-RS(4.1) were found to localize within the noncatalytic N-terminald omain of the enzyme and could be transferredt oa notherP ylRS variant, improving the ability of the variant to incorporate its corresponding ncAA substrate. This work introduces an efficient platform for the improvement of aaRSs that could be readily extended to other members of this enzyme familya nd/or other target ncAAs.
Here, we report the development of av ersatile platform useful for the engineering of aaRSs with enhanced efficiency for mediating ncAA incorporation through amber stopc odon suppression. This strategy was appliedt oe volve variants of Methanosarcina sp. PylRSs with significantly improved efficiency towardt he incorporation of N e -crotonyl-lysine (CrtK) and other lysine analogues relevant to the investigation of protein post-translational modifications into at arget protein. These studies also demonstrate the value of targeting noncatalytic regions of PylRS enzymes to improve their activity in the context of unnatural mutagenesis by amber stop codon suppression.
Results and Discussion
Two-tier functional screeningp latform for aaRS evolution Selection-based methods have provided av aluable and widely adopted strategy for aaRS engineering. [1a] These methods rely on coupling amber stop codon suppression to cell survival and death, as resulting from the expression of an antibiotic resistance marker (e.g.,c hloramphenicola cetyl transferase) in the presenceo fatargetn cAAa nd from the expressiono fatoxic protein (e.g.,b arnase) in the absence of the ncAA, respectively. Coupledw ith active site mutagenesis, this approach has provenh ighly effective for isolating aaRS variants with altered substrate specificity and orthogonal reactivity over natural amino acids, but various factorsm ake it suboptimal for evolving aaRSs with improvedn cAA incorporation efficiency. Among these factors is the difficulty of tunings tringency during the selectionp rocess without triggering survival mechanisms unrelated to the desired activity, [15] which can lead to ah igh frequencyo ffalse positives. [16] In addition, the use of an antibiotic resistance marker as ar eporter of ncAA incorporation implies that cell survival ensues when the essential enzymei sp roduced in sufficient amounts to generate antibiotic resistance, hampering the selection of aaRSv ariants with further improvedi ncorporation efficiency.I nt his regard, the use of reporter proteins such as green fluorescent protein (GFP) can provideamore reliable and quantitative meansf or monitoring aaRS-mediated ncAA incorporation, [17] but this approachh as found application mainly in the screening of small collections of aaRS variants, [17] [18] [19] with anotable exception.
[11d]
Based on these considerations,w ea imed to implement a two-tiers creening platform that could combine medium-/ high-throughput capability with aq uantitative readout of ncAA incorporationi nastreamlined manner.A so utlined in Figure 1 , this system was designed to comprise an initial phenotypics creen based on aL acZ reporter gene containing two ambers top codons (TAG). Efficient suppression of both stop codonsr esults in af unctional b-galactosidase enzyme, whose expression can be detected based on as tandard white/blue colonya ssay in the presence of the chromogenic substrate XGal (Figure 1, step A) . This step offers high-throughput capability (typically,u pt ot en-to 50 000-memberl ibraries), while uncouplingt he phenotypicr eadout (blue/white colony) from cell survival. It also permits af irst qualitative assessment of ncAA incorporation based on the blue color intensity of the colony. Positivec olonies (blue) identified in this first-tier screen are then arrayed on multiwell plates, in which the levels of ncAAcontaining galactosidasea re measured in aq uantitative manner by using as oluble, chromogenics ubstrate (para-nitrophenol-galactose or PNP-Gal;F igure 1, step B). As both experiments sharet he same reporter enzyme,t ransfer of the hits from the tier 1s creen to the tier 2s creen is both rapid and technically straightforward. Promising variants emerging from the tier 2screen can be subjected to another round of directed evolution (Figure1,s tep C) and/ore valuated by using as econdary functional assay ( Figure 1 , step D) in which the incorporation efficiency of the evolved aaRS is measured by using a yellow fluorescent protein (YFP) reporterp rotein containing an amber stop (TAG) codon at ap ermissive site. The orthogonal reactivityo ft he evolveda aRS enzyme toward the desired ncAA over the natural amino acids can be assessed by comparing b-galactosidase activity (Tier-2 screen) or YFP expression (secondary assay) in the presence and absence of the ncAA. A Figure 1 . Schematic overview of the two-tier screening system for aaRS evolution.A)Alibraryofe ngineered aaRS variants is first subjected to ap henotypic screen by using E. coli cells containing aL acZ(2xTAG) gene. aaRS-mediated amber stop codon suppression with the target ncAA leads to the expressionof af unctional b-galactosidase enzymea nd processing of X-gal substrate. B) Positive clones (blue colonies) are then evaluated in ap late-based b-galactosidase activitya ssay with PNP-Gal, enabling quantification of ncAA suppression efficiency. C) Improved aaRSs are subjected to another round of directed evolution or,alternatively, D) evaluated for improvedncAA suppression efficiency by using the YFP(TAG)reporter protein. ChemBioChem 2017 ChemBioChem , 18,1 109 -1116 www.chembiochem.org 2017 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim dual vector system, in which one plasmid directs the expression of the reporter protein (b-galactosidaseo rY FP), and a second plasmide ncodes for the aaRS/tRNA pair,f acilitates the transfer of the aaRS-encoding plasmid from the tier 2s creen to the YFP-based functional assay.O fn ote, the LacZ gene was previously used as ar eporter for amber stop codon suppression, [20] but it has never been applied to guide the engineering of aaRS enzymes.
Directede volution of crotonyl-lysyl-tRNA synthetase
Ap reviously reported Methanosarcina barkeri PylRS variant (CrtK-RS)
[4e] capable of recognizing crotonyll ysine (CrtK, Figure 2A) w as selected as the target aaRS for validating the system outlined above.L ysine crotonylation is ar are form of protein post-translationalm odification (PTM), [21] and CrtK-RS has provenu seful for the preparation andf unctional investigation of histone proteins bearing this PTM at selected positions. [22] Randomm utagenesis was applieda st he evolutionary tool in order to identity mutationst hat coulde nhance PylRSmediated ncAA incorporation while having minimal impact on the substrate recognition properties and selectivity of the enzyme.T he latter result was anticipated, given that amino acid residues in direct contact with the substrate represent only as mall fraction (< 3%)o ft he entire amino acids equence of PylRS.
Accordingly,a ni nitial random mutagenesis library of CrtK-RS variants (Lib-G1; % 10 4 members) was generatedb yu sing error-prone PCR under conditions that yieldeda ne stimated mutationalr ate of 2.4 nucleotide mutations per gene. The enzyme library was expressed in E. coli TOP10F' cells containing al ow-copy-number plasmid encodingt he LacZ alpha fragment with two amber stop codonsw ithin the N-terminal region. Upon growth on lysogenybroth(LB) agar medium supplementedw ith CrtK and X-gal, recombinant colonies expressing functional b-galactosidase as ar esult of CrtK incorporation were readily identified as blue colonies ( % 20 %o fp lated library). Based on color intensity,a bout 90 positive hits were then arrayed and rescreened in a9 6-well plate format. Upon cell lysis, b-galactosidase activity was quantified in ac olorimetric assay with para-nitrophenol-galactose, with the absorbance intensity thus providing aq uantitative measure of the efficiency of CrtK suppressionb ya ction of the CrtK-RS mutant (Figure 2B ). Upon rescreening, five improved CrtK-RS variants were identified from the initial Lib-G1 library, as evidencedb yt he 1.5-to 2.5-fold higher b-galactosidase activity measured in the assay compared to the parent enzyme ( Figure 2C ). Among them,t he most promising variant, G1.1, was determined to contain as ingle mutation at position 36 (Table 1) .
Following as imilar strategy,asecond-generation random mutagenesis library( Lib-G2) was prepared and screenedb y using G1.1 as the parent enzyme. This process yieldedafurther improved PylRS variant, G2.1 ( Figure S1 Bi nt he Supporting Information), which carriest wo mutations( T13I and I253V)i n addition to the preexisting I36V substitution (Table 1) . Starting from G2.1, athird round of randommutagenesis and screening led to identification of CrtK-RSv ariant G3.1 ( Figure S1 D) , which containsana dditional mutation at position 121 (S121R). At this point,arecombination library (Lib-G4) was prepared by shuffling the genes corresponding to G3.1 and to the 4-5 best performing variants identified after each round of directed evolution. Screeningo ft his library resulted in the identification of four CrtK-RS variants with increased suppression efficiency compared to G3.1 based on the b-galactosidase assay (Figure S1 F) . Amongt hem, the most promising variant (G4.1) was namedC rtK-RS(4.1) and selected for further analysis.
Functionalanalysis and location of mutations in CrtK-RS(4.1)
Sequence analysisr evealed that CrtK-RS(4.1) contains at otal of six amino acid substitutions, namely V8E, T13I, I36V,H 45L, S121R, and I355T.T hree of these mutationsw ere shared with G3.1 (Table 1) , whereas the V8E mutation could be traced back to one of the improved variants isolated after the third round of directed evolution (G3.3;T able S2). The beneficial effect of each of these mutations was evident from side-by-side comparisono fr elatedv ariants identified throughout the process and with respectt ot heir relative ncAA incorporation efficiency, as measured by the b-galactosidase assay (Figure 2a nd Figure S1 ). For example, whereas two mutationsw ere accumulated during the transition from G1.1 to G2.1,t he functional importance of each of them became apparent from comparison of b-galactosidase activity observed with G2.5 compared to G2.1 (T13I mutation)a nd with G2.1 compared to G2.3 (I253V Figure S1 ). Interestingly,d uring the DNA shuffling step (G3.1!G4.1), the T13 mutation was maintained, whereas the comparatively less important I253V mutation was not. In contrast to the aforementioned mutations, the H45L and I355T substitutions were not present in the original pool of genes used for recombination and thusw ere most likely introduced during assembly and/or amplification of the shuffled DNA library. To examine the functional importance of these unexpected mutations, reversion variants were generated in which each of these substitutions was removed from CrtK-RS(4.1). Analysis of these CrtK-RS variants confirmed that both mutations provide ab eneficial, albeit relativelym odest,a ctivity improvement (+ +20 %; Figure S2 ). Based on the analyses outlined above,w ec oncluded that all of the mutationsa ccumulated in the best-performing variant, CrtK-RS(4.1), contribute to its improved activity for CrtK incorporation through amber stop codon suppression in bacterial cells.
Mb PylRS is a4 7.5 KDa class II aminoacyl-tRNA synthetase comprising an N-terminal domain (residues 1-194) and aC -terminal domain (residues 210-419) connected throughalinker region (16 residues) . [23] The C-terminal domain encompasses the catalytic site involved in the activation of pyrrolysine as an aminoacyl-AMPa dduct andi ts subsequent conjugationt ot he tRNA molecule. The N-terminal domain was previously determined to be important for tRNA binding [24] and essential for in vivo activity. [23] In light of this information, it is particularly interesting to note that the largest majority of the beneficial mutations (10/13 = 77 %), accumulated in CrtK-RS(4.1) and identified throughout the courseo ft he directed evolution experiment (Tables 1and S2) , was localized within the N-terminal, noncatalytic domain of the enzyme.T he only exception was I355T,w hichr esides within the C-terminal catalytic domain but at arather distantlocation with respect to the bound substrate ( % 12-15 ) , as derived by inspection of the homologous C-terminal domain of M. mazei PylRS ( Figure S3) . [25] Ther elative contributiono ft his particularmutation to the improved properties of CrtK-RS(4.1) is, however,m odest compared to the other mutations ( Figure S2 ). Thus, whereas prior PylRS engineering efforts have largely relied on mutating the actives ite of these enzymes, [7b] our results indicate that there are significant opportunities to enhancet he amber stop codon efficiency of these enzymes through mutation of their noncatalytic N-terminal domain. Although the mechanisms of the beneficial mutations within this region are currently unclear,t he native function of this domain suggestst hat they might be related to improvingt he interaction of the enzymes with their cognate tRNA molecules and/or other cellular components.
Improved CrtK incorporation efficiency
In E. coli cultures grown in flasks, CrtK-RS(4.1) wasd etermined to exhibit a3 70 %i mprovement in CrtK incorporation efficiency based on the b-galactosidasea ssay ( Figure 3A) . To further assess the enhanced performance of the evolvedPylRS variants toward mediating the ribosomal incorporation of CrtK into ap rotein of interest, aY FP variant containing an N-terminal amber stop codon was used. As shown in Figure 3B ,p rogressive improvement in the expression levels of YFP(CrtK) was observedi nt he presence of the evolveda aRS enzymes,at rend consistentw ith that obtained with b-galactosidasea st he reporterp rotein ( Figure 3A) . Based on the YFP reporter protein, CrtK-RS(4.1) showed a2 50 %h igherC rtK incorporation efficiency compared to the initial enzyme. In addition, minimal levels of background expression were observed in both assays with cells growni nt he absence of CrtK ( Figure 3A and B), indicating that all evolvedC rtK-RS variants maintained high specificity toward the ncAA over the pool of natural amino acids. This result wasc onsistentw ith the observation that all of the beneficial mutationsa ccumulated in these variants were located in positionsr emote from the enzyme active site. To confirmt he selectivei ncorporation of CrtK, YFP expressed in the presence of CrtK-RS(4.1) was purified by Ni-NTAa ffinity chromatography and characterized by SDS-PAGE and LC-MS ( Figure 4) . The observedm ass of this protein was found to match the expected one, thus confirming efficient and specific incorporation of CrtK.
Improvedefficiencyfor incorporation of other N e -acylated lysine analogues
In addition to N e -crotonyl-lysine and N e -acetyl-lysine (AcK), other N e -acylated formso fl ysine have been identified as a result of post-translational modification events in eukaryotic organisms, including N e -propionyl (PrK) and N e -butyryl lysine (BuK). [26] As these modified lysine analogues are poorly recognized by wild-type PylRS, [4f, 22] PylRS variants have been engineered to incorporate these analogues into proteins with vary- ing degrees of substrate specificity. [22] In the interest of examining whether the improved properties of CrtK-RS(4.1) extended to other lysine analogues beyond CrtK, the incorporation of BuK, PrK, and AcK in the presenceo ft he evolveda aRS was investigated ( Figure 5A ). These experiments showed CrtK-RS(4.1) was able to provide improved expression yields for BuK-containing YFP (+ +220 %) as well as for the PrK-containing counterpart, which could not be obtainedb yu sing the parentC rtK-RS enzyme.N egligible levels of AcK-containing YFP were obtained with both CrtK-RSa nd CrtK-RS(4.1), indicating that the enhanced properties of the evolved CrtK-RS variant were mostly confinedt ol ysine analogues that contain as ide-chain acyl group of similarlength to that of CrtK.
Transferability of activity-enhancing mutations to other Mb PylS variants
Our finding that the beneficial mutations carried by CrtK-RS(4.1) were clustered within the N-terminal domain of the enzymef urther suggested that they could be potentially transferred to other Mb PylRS variants. Indeed, Mb PylRS variants evolvedf or recognition of different lysine derivatives typically differ from each other by amino acid substitutions localized only within the substrate binding pocket. To examine this point, the six mutations identified in CrtK-RS(4.1) were introduced into a Mb PylRS variant (AynK-RS) previously reported for the incorporation of the alkyne-containing ncAA N e -[(2-propynyloxy)carbonyl]-l-lysine (AynK). [27] To our delight, a2 .2-fold improvement in expression levels for the model YFPp rotein was observed in the presence of the modified AynK-RS enzyme, AynK-RS(4.1), compared to AynK-RS under identical experimental conditions ( Figure 5B ). Also, in this case, the improvement in incorporation efficiency for the corresponding ncAA did not come at the expense of specificity,a si ndicated by the comparably low levelso fb ackground fluorescence measured upon protein expression in the absence of AynK.
Conclusion
In conclusion, this work introduced and validated an efficient platform for the directed evolution and improvement of aaRS enzymes.P articularlya dvantageous features are the combination of high-throughput capability,a se nabled by the phenotypic white/blue colony screen, with aq uantitative readouto f ncAA incorporation from at andemf unctional assay.A ss uch, this system provides av aluablec omplementt oe stablished selection-based methods for the discovery andi mprovement of orthogonal aaRS/tRNAp airs for geneticc ode expansion. By using the present approach, an improved PylRS variant was obtained for the incorporation of crotonyl-lysine and other Nacylated lysinea nalogues associated with human PTMs into ap rotein of interest. This evolved aaRS is expected to contribute av aluable andv ersatile tool for the production of proteins modified site-selectively with crotonyl, propionyl, or butyryl lysine,t hus facilitating efforts toward elucidating the functional roles of these forms of PTMs.
Finally,t hese studies provide af irst-time demonstration of the value of mutating the N-terminal, noncatalytic domain of PylRS enzymes to enhance their amber stop codon suppression efficiency in vivo. Importantly,t hesem utationsd id not affect the specificityo ft he aaRS and could be transferred to another Mb PylRS variant,l eading to as ignificant improvement in suppression efficiency for its corresponding ncAA. These findings are expected to aid future efforts in PylRS engineering and suggestt hat domain engineering strategies [28] could be useful forthe evolution of this class of enzymes. 
Experimental Section
Plasmid construction: Custom-made oligonucleotides were purchased from IDT DNA Te chnologies, and their sequences are reported in Ta ble S1. The vector encoding the LacZ(2xTAG) gene (pZS13_LacZ_2x_Stop) was derived from the low-copy-number plasmid pZS13 (Expressys), which contains ap SC101 origin of replication and an ampicillin marker (bla). pZS13_LacZ_2x_Stop was prepared by PCR amplification of the LacZ alpha gene by using primers LacZ2X_F and LacZ2X_R, followed by cloning of the resulting PCR product into the NcoI/XbaI cassette of pZS13. This process placed the LacZ(2xTAG) gene, which contains aT AG codon, in place of Met3 and Ser7, under an IPTG-inducible promoter (P A1lacO-1 ). The preparation of the plasmid encoding for the YFP(TAG) protein (pET22_YFP_1X_Stop) was described previously.
[5e] The CrtK-RS/tRNA pair was encoded by am odified form of the pEVOL [9a] vector-pEVOL(1x)-which contains ap 15A origin of replication and chloramphenicol marker (cat). In this plasmid, one copy of the aaRS gene is under an arabinose-inducible (araBAD) promoter, whereas the tRNA gene is under ac onstitutive proK promoter.F or library generation, the CrtK-RS gene was amplified by using primers CrtK_F and CrtK_R and inserted into the BglII and SalI cassette of the pEVOL(1x) vector.T he ligation product was transformed into DH5a cells and plated on LB agar plates supplemented with chloramphenicol (34 mgmL
À1
). AynK-RS G4.1 was generated by swapping the N-terminal domain of AynK-RS with that of G4.1, followed by introduction of the I355T mutation. The N-terminal domain of G4.1 was amplified with primers SOE_G4.1F and SOE_G4.1R and fused to the C-terminal region of the AynK-RS gene (amplified with primers SOE_AynKF and SOE_AynKR) by sequential overlap extension (SOE). With the SOE product as at emplate, mutation I355T was inserted by as econd SOE reaction using gene fragments generated with primers SOE_G4.1F/SOE_I355TR and SOE_I355TF/SOE_AynKR. With CrtK-RS(4.1) as at emplate, CrtK-RS(4.1)-T355I was generated by SOE using gene fragments generated from amplification of SOE_G4.1F/ SOE_T355I_R and SOE_T355I_ F/SOE_G4.1_R. CrtK-RS(4.1)-L45H was generated in the same way by using CrtK-RS(4.1) as at emplate and the gene products of SOE_ G4.1F/SOE_L45H Ra nd SOE_L45H_F/ SOE_G4.1_R in aS OE reaction. All plasmids and library clone sequences were confirmed by DNA sequencing.
Library preparation: The CrtK gene was mutagenized by errorprone PCR using Taq polymerase (NEB), oligonucleotides CrtK_F and CrtK_R as primers, and the plasmid encoding for CrtK-RS, G1.1, or G1.2 as template. The PCR reaction was performed by using a standard reaction mixture supplemented with dTTP (1.0 mm), dCTP (1.0 mm), MgCl 2 (3.5 mm)a nd MnCl 2 (0.2 mm). This error-prone PCR protocol was previously reported to provide minimal bias in nucleotide misincorporation. [29] The PCR product was amplified according to the method:2min at 95 8C( 1c ycle);3 0sat 95 8C, 30 s at 60 8C, 1min 30 sa t7 28C( 20 cycles). The resulting PCR product (1.2 Kbp) was ligated into the BglII and SalI cassette of the pEVOL(1x) vector.T he average error rate for the library was determined by sequencing ten randomly chosen recombinant colonies. The DNA shuffling library was generated by first pooling the PCR products from each top preforming aaRS variant (G1.1-G3.5) by using primers ePCR_F and ePCR_R and Taq polymerase (NEB). The genes were mixed in equal amounts to reach af inal DNA concentration was 1 mgmL
.T he DNA was digested with DNase I( NEB) for 4min at room temperature in the presence of MnCl 2 (10 mm) and immediately purified by agarose gel electrophoresis. DNA fragments between 10-100 bp were collected and reassembled by using Taq polymerase according to the method:2min at 95 8C( 1 cycle);3 0sat 95 8C, 30 sa t6 08C, 1min at 72 8C( 45 cycles). The resulting 1.2 kbp product was ligated into the BglII and SalI cassette of the pEVOL(1x) vector,t ransformed into DH5a cells and plated on LB agar plates supplemented with chloramphenicol (34 mgmL À1 ).
Library screening: For library screening, each plasmid library was co-transformed with pZS13_LacZ_2x_Stop in TOP10F' cells and plated on LB agar plates supplemented with ampicillin (100 mgmL À1 ), chloramphenicol (34 mgmL À1 ), arabinose (0.06 %), IPTG (1 mm), X-Gal (20 mgmL À1 ), and CrtK (2 mm). After incubation for 18 ha t3 78C, blue colonies were selected from the plates and regrown to saturation (overnight) in am aster 96-deep-well plate containing LB medium (1 mL per well), supplemented with ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL À1 ). Ar eplicate plate with M9 medium (1 mL per well) containing ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL À1 )w as generated from the master plate and grown to an OD 600 of 0.5-0.6, followed by addition of arabinose (0.06 %) and CrtK (2 mm). After 1h at 37 8C, the wells were induced with IPTG (1 mm)a nd grown for 18 h at 27 8C. Cells were recovered by centrifugation at 4300 g in a swinging plate rotor,a nd decanted pellets were frozen at À80 8C. The cell pellets were then resuspended in lysis buffer (50 mm potassium phosphate, 150 mm NaCl, 10 mm MgCl 2 ,0 .8 mgmL
DNase, and 0.8 mgmL À1 lysozyme, pH 7.5) and incubated at 37 8C for 1hand 15 min. Insoluble cellular debris was pelleted by centrifugation at 4300 g at 4 8C. The clarified lysate (130 mL) was transferred to a9 6-well microtiter plate, and para-nitrophenol-galactose in Kpi buffer (20 mLo fa37.5 mm solution;f inal concentration of 5mm)w as added, followed by incubation at 37 8Ci na no rbital shaker (120 rpm) for 20 min. Absorbance at 420 nm was monitored by using aT ecan Infinity 1000 plate reader.P ositive hits identified at this stage were rescreened in triplicate according to the same procedure as described above. Plasmids encoding the most promising aaRS variants were then isolated from the master plate by plasmid extraction from overnight culture, followed by digestion with EcoRI and separation of the pEVOL(1x)-based plasmid from digested pZS13_LacZ_2x_Stop plasmid by gel electrophoresis. The purified pEVOL(1x)-based plasmids were re-transformed into DH5a cells, and transformant cells were selected on LB agar plates containing chloramphenicol (34 mgmL
). Mutations in the aaRS gene were identified by DNA sequencing.
YFP assay: The plasmid encoding YFP(TAG) and the pEVOL(1x)-based vector encoding the desired aaRS were co-transformed in BL21(DE3) cells and grown to saturation in LB medium supplemented with ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL À1 ). Overnight cultures were used to inoculate M9 medium (1 mL per well), supplemented with ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL À1 ), in a9 6-deep-well plate and were then allowed to reach an OD 600 of 0.5-0.6. Cultures were then induced with arabinose (0.06 %), ncAA (2 mm)w as added, and cultures were grown at 37 8Cf or 1h.C ultures were then induced with IPTG (1 mm)a nd grown for 18 ha t2 78C. Control cultures were prepared in as imilar manner but without ncAA addition. Fluorescence measurements were obtained from cell cultures (150 mL) by using aT ecan Infinity 1000 plate reader (l ex = 514 nm, l em = 527 nm). Mean values and errors were obtained from three independent experiments. b-Galactosidase assay: The plasmid encoding pZS13_LacZ_2x_ Stop and the pEVOL(1x)-based vector encoding the desired aaRS were co-transformed in TOP10F' cells and grown to saturation in LB medium supplemented with ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL
). Overnight cultures were used to in- ChemBioChem 2017 ChemBioChem , 18,1 109 -1116 www.chembiochem.org ), and cultures were allowed to reach an OD 600 of 0.5-0.6. Cultures were then induced with arabinose (0.06 %), CrtK (2 mm)w as added, and the cultures were grown at 37 8Cf or 1h.C ultures were then induced with IPTG (1 mm)a nd grown for 18 ha t2 7 8C. Control cultures were prepared in as imilar manner but without addition of CrtK. Cells were recovered by centrifugation at 4300 g. The cells were then resuspended in lysis buffer (50 mm potassium phosphate, 150 mm NaCl, 10 mm MgCl 2 ,0 .8 mgmL À1 DNase, and 0.8 mgmL À1 lysozyme, pH 7.5) and incubated at 37 8Cf or 1h and 15 min. Insoluble cellular debris was pelleted by centrifugation at 4300 g. The clarified lysate (130 mL) was transferred to a9 6-well microtiter plate, and para-nitrophenol-galactose in Kpi buffer (20 mLo fa37.5 mm solution;f inal concentration 5mm)w as added, followed by incubation at 37 8Ci na no rbital shaker (120 rpm) for 20 min. Absorbance at 420 nm was monitored by using aT ecan Infinity 1000 plate reader. Mean values and errors were obtained from three independent experiments.
Protein expression and isolation: BL21(DE3) cells were transformed with the plasmid pET22_YFP_1X_Stop and pEVOL(1x) plasmids and grown in LB medium with ampicillin (100 mgmL À1 )a nd chloramphenicol (34 mgmL À1 )o vernight. YFP(CrtK) expression was carried out in M9 medium (250 mL) as described above. Cells were harvested by centrifugation at 4300 g,a nd cell pellets were resuspended in imidazole-Tris buffer (10 mL;4 0mm Tris·HCl, 150 mm NaCl, 20 mm imidazole, pH 7.5) and purified by Ni-NTAc hromatography (Qiagen) as per the manufacturer's instructions. After elution from the Ni-NTAc olumn, the protein was concentrated and the buffer exchanged with potassium phosphate buffer (50 mm potassium phosphate, 150 mm NaCl, pH 7.5). The purified protein was analyzed by LC-(ESI)-MS using aT hermoFisher Accela HPLC coupled to aT hermoFisher ESI-IT Velos Mass Spectrometer.
